vs
Side-by-side financial comparison of AVIENT CORP (AVNT) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $760.6M, roughly 1.8× AVIENT CORP). AVIENT CORP runs the higher net margin — 2.2% vs 1.4%, a 0.8% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs 1.9%). AVIENT CORP produced more free cash flow last quarter ($125.4M vs $5.2M). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs -4.2%).
Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
AVNT vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $760.6M | $1.4B |
| Net Profit | $16.9M | $20.2M |
| Gross Margin | 30.2% | — |
| Operating Margin | 5.2% | 4.6% |
| Net Margin | 2.2% | 1.4% |
| Revenue YoY | 1.9% | 6.4% |
| Net Profit YoY | -65.0% | 225.7% |
| EPS (diluted) | $0.18 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $760.6M | $1.4B | ||
| Q3 25 | $806.5M | $1.4B | ||
| Q2 25 | $866.5M | $1.3B | ||
| Q1 25 | $826.6M | $1.4B | ||
| Q4 24 | $746.5M | $1.3B | ||
| Q3 24 | $815.2M | $1.3B | ||
| Q2 24 | $849.7M | $1.3B | ||
| Q1 24 | $829.0M | $1.3B |
| Q4 25 | $16.9M | $20.2M | ||
| Q3 25 | $32.6M | $28.8M | ||
| Q2 25 | $52.6M | $40.6M | ||
| Q1 25 | $-20.2M | $56.7M | ||
| Q4 24 | $48.3M | $-16.1M | ||
| Q3 24 | $38.2M | $55.6M | ||
| Q2 24 | $33.6M | $77.6M | ||
| Q1 24 | $49.4M | $96.9M |
| Q4 25 | 30.2% | — | ||
| Q3 25 | 30.4% | — | ||
| Q2 25 | 32.1% | — | ||
| Q1 25 | 31.8% | — | ||
| Q4 24 | 34.8% | — | ||
| Q3 24 | 32.1% | — | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 33.6% | — |
| Q4 25 | 5.2% | 4.6% | ||
| Q3 25 | 8.3% | 5.4% | ||
| Q2 25 | 11.1% | 6.5% | ||
| Q1 25 | 0.1% | 8.3% | ||
| Q4 24 | 11.5% | 1.6% | ||
| Q3 24 | 9.5% | 4.3% | ||
| Q2 24 | 8.5% | 5.8% | ||
| Q1 24 | 11.3% | 9.0% |
| Q4 25 | 2.2% | 1.4% | ||
| Q3 25 | 4.0% | 2.1% | ||
| Q2 25 | 6.1% | 3.0% | ||
| Q1 25 | -2.4% | 4.2% | ||
| Q4 24 | 6.5% | -1.2% | ||
| Q3 24 | 4.7% | 4.4% | ||
| Q2 24 | 4.0% | 6.1% | ||
| Q1 24 | 6.0% | 7.3% |
| Q4 25 | $0.18 | $0.17 | ||
| Q3 25 | $0.36 | $0.23 | ||
| Q2 25 | $0.57 | $0.32 | ||
| Q1 25 | $-0.22 | $0.44 | ||
| Q4 24 | $0.53 | $-0.12 | ||
| Q3 24 | $0.41 | $0.43 | ||
| Q2 24 | $0.36 | $0.60 | ||
| Q1 24 | $0.54 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $26.5M |
| Total DebtLower is stronger | $1.9B | $1.8B |
| Stockholders' EquityBook value | $2.4B | $1.7B |
| Total Assets | $6.0B | $5.9B |
| Debt / EquityLower = less leverage | 0.81× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $26.5M | ||
| Q3 25 | — | $60.1M | ||
| Q2 25 | — | $52.3M | ||
| Q1 25 | — | $53.2M | ||
| Q4 24 | — | $59.7M | ||
| Q3 24 | — | $191.5M | ||
| Q2 24 | — | $111.2M | ||
| Q1 24 | — | $92.6M |
| Q4 25 | $1.9B | $1.8B | ||
| Q3 25 | $2.0B | $1.7B | ||
| Q2 25 | $2.0B | $1.8B | ||
| Q1 25 | $2.1B | $1.8B | ||
| Q4 24 | $2.1B | $1.7B | ||
| Q3 24 | $2.1B | $3.1B | ||
| Q2 24 | $2.1B | $3.6B | ||
| Q1 24 | $2.1B | $3.8B |
| Q4 25 | $2.4B | $1.7B | ||
| Q3 25 | $2.4B | $1.7B | ||
| Q2 25 | $2.4B | $1.7B | ||
| Q1 25 | $2.3B | $1.7B | ||
| Q4 24 | $2.3B | $1.7B | ||
| Q3 24 | $2.4B | $1.9B | ||
| Q2 24 | $2.3B | $1.4B | ||
| Q1 24 | $2.3B | $1.4B |
| Q4 25 | $6.0B | $5.9B | ||
| Q3 25 | $6.1B | $5.7B | ||
| Q2 25 | $6.1B | $5.7B | ||
| Q1 25 | $5.8B | $5.7B | ||
| Q4 24 | $5.8B | $5.6B | ||
| Q3 24 | $6.0B | $8.0B | ||
| Q2 24 | $5.9B | $7.9B | ||
| Q1 24 | $5.9B | $7.9B |
| Q4 25 | 0.81× | 1.06× | ||
| Q3 25 | 0.83× | 1.03× | ||
| Q2 25 | 0.86× | 1.10× | ||
| Q1 25 | 0.90× | 1.03× | ||
| Q4 24 | 0.89× | 1.01× | ||
| Q3 24 | 0.88× | 1.62× | ||
| Q2 24 | 0.90× | 2.54× | ||
| Q1 24 | 0.90× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $167.8M | $64.3M |
| Free Cash FlowOCF − Capex | $125.4M | $5.2M |
| FCF MarginFCF / Revenue | 16.5% | 0.4% |
| Capex IntensityCapex / Revenue | 5.6% | 4.2% |
| Cash ConversionOCF / Net Profit | 9.93× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $195.0M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.8M | $64.3M | ||
| Q3 25 | $72.1M | $175.3M | ||
| Q2 25 | $112.8M | $110.3M | ||
| Q1 25 | $-51.1M | $-3.5M | ||
| Q4 24 | $122.6M | $125.4M | ||
| Q3 24 | $71.1M | $181.0M | ||
| Q2 24 | $105.9M | $278.2M | ||
| Q1 24 | $-42.8M | $-66.7M |
| Q4 25 | $125.4M | $5.2M | ||
| Q3 25 | $47.4M | $122.2M | ||
| Q2 25 | $85.8M | $45.6M | ||
| Q1 25 | $-63.6M | $-55.8M | ||
| Q4 24 | $81.5M | $62.0M | ||
| Q3 24 | $46.1M | $130.3M | ||
| Q2 24 | $74.5M | $222.6M | ||
| Q1 24 | $-67.2M | $-119.2M |
| Q4 25 | 16.5% | 0.4% | ||
| Q3 25 | 5.9% | 9.0% | ||
| Q2 25 | 9.9% | 3.4% | ||
| Q1 25 | -7.7% | -4.1% | ||
| Q4 24 | 10.9% | 4.7% | ||
| Q3 24 | 5.7% | 10.2% | ||
| Q2 24 | 8.8% | 17.4% | ||
| Q1 24 | -8.1% | -9.0% |
| Q4 25 | 5.6% | 4.2% | ||
| Q3 25 | 3.1% | 3.9% | ||
| Q2 25 | 3.1% | 4.8% | ||
| Q1 25 | 1.5% | 3.9% | ||
| Q4 24 | 5.5% | 4.8% | ||
| Q3 24 | 3.1% | 4.0% | ||
| Q2 24 | 3.7% | 4.3% | ||
| Q1 24 | 2.9% | 4.0% |
| Q4 25 | 9.93× | 3.19× | ||
| Q3 25 | 2.21× | 6.09× | ||
| Q2 25 | 2.14× | 2.72× | ||
| Q1 25 | — | -0.06× | ||
| Q4 24 | 2.54× | — | ||
| Q3 24 | 1.86× | 3.25× | ||
| Q2 24 | 3.15× | 3.59× | ||
| Q1 24 | -0.87× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNT
| Color Additives And Inks | $466.0M | 61% |
| Specialty Engineered Materials | $295.5M | 39% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
